Valuation: McKesson Corporation

Market Cap 94.36B 82.54B 76.13B 70.31B 133B 8,999B 136B 910B 357B 4,433B 354B 347B 15,241B P/E 2027 *
19.1x
P/E 2028 * 16.8x
Enterprise Value 99.16B 86.74B 80B 73.89B 140B 9,457B 143B 956B 375B 4,659B 372B 364B 16,017B EV / Sales 2027 *
0.23x
EV / Sales 2028 * 0.21x
Free-Float
42.23%
Yield 2027 *
0.41%
Yield 2028 * 0.44%
1 day+3.32%
1 week+3.55%
Current month+7.57%
1 month+4.38%
3 months-5.19%
6 months-2.26%
Current year-1.46%
1 week 784.5
Extreme 784.5
826.9
1 month 735
Extreme 735
826.9
Current year 710.01
Extreme 710.01
1,016.97
1 year 637.28
Extreme 637.285
1,016.97
3 years 397
Extreme 397
1,016.97
5 years 187.02
Extreme 187.0235
1,016.97
10 years 108.34
Extreme 108.34
1,016.97
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2019
Chief Tech/Sci/R&D Officer 53 03/10/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 75 01/04/2022
Director/Board Member 70 24/04/2018
Chairman 59 01/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
+3.32%+3.55% - - 94.36B
-0.63%-1.30%+44.99%+150.95% 55.23B
+3.55%+4.66%+2.10%+269.62% 22.56B
+1.24%+1.30%-14.05%-22.35% 8.01B
-0.75%-2.96%-27.34%-35.23% 7.6B
+0.72%+0.66%-10.56%-27.84% 6.66B
-1.55%-2.79%+20.94%+34.64% 6.25B
+0.92%+1.74%-1.63%+23.94% 5.36B
+1.00%+2.43%-5.24%-6.08% 3.68B
+0.95%+0.59%+12.25%+16.43% 3.34B
Average +0.90%+0.15%+2.38%+44.90% 13.19B
Weighted average by Cap. +1.74%-0.35%+19.25%+119.34%

Financials

2027 *2028 *
Net sales 431B 377B 348B 321B 610B 41,126B 620B 4,157B 1,632B 20,260B 1,619B 1,584B 69,649B 463B 405B 374B 345B 655B 44,204B 666B 4,468B 1,755B 21,776B 1,740B 1,702B 74,863B
Net income 4.93B 4.31B 3.97B 3.67B 6.96B 470B 7.08B 47.48B 18.65B 231B 18.5B 18.09B 796B 5.41B 4.73B 4.37B 4.03B 7.65B 516B 7.78B 52.18B 20.49B 254B 20.32B 19.88B 874B
Net Debt 4.8B 4.2B 3.87B 3.58B 6.79B 458B 6.9B 46.27B 18.17B 226B 18.02B 17.63B 775B 4.55B 3.98B 3.67B 3.39B 6.43B 434B 6.54B 43.83B 17.21B 214B 17.07B 16.7B 734B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change Volume
13/07/26 $812.89 +3.84% 22
10/07/26 $803.71 +1.80% 664
09/07/26 $789.50 -3.42% 476
08/07/26 $817.44 +1.58% 242
07/07/26 $804.69 +2.51% 309
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
805.96USD
Average target price
942.07USD
Spread / Average Target
+16.89%

Quarterly revenue - Rate of surprise